[{"orgOrder":0,"company":"Pohl Boskamp","sponsor":"Universit\u00e4tsklinikum Hamburg-Eppendorf","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"GERMANY","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Dimethicone","moa":"Skin barrier","graph1":"Dermatology","graph2":"Phase II","graph3":"Pohl Boskamp","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pohl Boskamp \/ Universit\u00e4tsklinikum Hamburg-Eppendorf","highestDevelopmentStatusID":"8","companyTruncated":"Pohl Boskamp \/ Universit\u00e4tsklinikum Hamburg-Eppendorf"},{"orgOrder":0,"company":"ProTechSure Scientific","sponsor":"Poudre Valley Health System","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Dimethicone","moa":"Skin barrier","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Phase I\/ Phase II","graph3":"ProTechSure Scientific","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Cream","sponsorNew":"ProTechSure Scientific \/ Poudre Valley Health System","highestDevelopmentStatusID":"7","companyTruncated":"ProTechSure Scientific \/ Poudre Valley Health System"},{"orgOrder":0,"company":"Hackensack Meridian Health","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Dimethicone","moa":"Skin barrier","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Hackensack Meridian Health","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hackensack Meridian Health \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Hackensack Meridian Health \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Silicone DC 360 fluid

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          ProTechSure Scientific

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          ProTechSure Scientific

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Dimethicone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Radiodermatitis.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 27, 2015

                          Lead Product(s) : Dimethicone

                          Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Poudre Valley Health System

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Dimethicone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pediculus.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 11, 2014

                          Lead Product(s) : Dimethicone

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Dimethicone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Psoriasis.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 02, 2013

                          Lead Product(s) : Dimethicone

                          Therapeutic Area : Dermatology

                          Highest Development Status : Phase II

                          Sponsor : Universitätsklinikum Hamburg-Eppendorf

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank